These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 6819843)

  • 21. Expression of myeloid differentiation antigens on normal and malignant myeloid cells.
    Griffin JD; Ritz J; Nadler LM; Schlossman SF
    J Clin Invest; 1981 Oct; 68(4):932-41. PubMed ID: 6945311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maturation linked expression of a myeloid cell surface antigen.
    Roberts MM; Greaves MF
    Br J Haematol; 1978 Apr; 38(4):439-52. PubMed ID: 348227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell surface markers in leukemia: biological and clinical correlations.
    Thiel E
    Crit Rev Oncol Hematol; 1985; 2(3):209-60. PubMed ID: 3013441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Membrane marker analysis of 'lymphoid' and myeloid blast crisis in PH1 positive (chronic myeloid) leukemia.
    Janossy G; Greaves MF; Capellaro D; Roberts M; Goldstone AH
    Haematol Blood Transfus; 1977; 20():97-107. PubMed ID: 305406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibody-producing human-human hybridomas. III. Derivation and characterization of two antibodies with specificity for human myeloid cells.
    Andreasen RB; Olsson L
    J Immunol; 1986 Aug; 137(3):1083-90. PubMed ID: 3459756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunological distinction of adult T cell leukaemia from T cell acute lymphoblastic leukaemia.
    Tsubota T; Miyoshi I; Uno J; Hiraki S; Kobayashi T; Sato U; Kimura I
    Clin Exp Immunol; 1980 Jul; 41(1):130-5. PubMed ID: 6969147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection and partial characterization of human thymus-leukemia antigens.
    Dowell BL; Falletta JM; Moore JO; Metzgar RS
    J Natl Cancer Inst; 1980 Oct; 65(4):691-701. PubMed ID: 6968369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stimulating capacity of blast cells from patients with chronic myelocytic leukaemia, in blastic crisis in 'one-way' mixed lymphoycte reaction: lack of evidence for T lymphoblastic conversion.
    Han T; Gomez GA; Minowada J
    Immunology; 1978 Aug; 35(2):299-305. PubMed ID: 155646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human monocyte-histiocyte differentiation antigens identified by monoclonal antibodies.
    Kamoun M; Martin PJ; Kadin ME; Lum LG; Hansen JA
    Clin Immunol Immunopathol; 1983 Nov; 29(2):181-95. PubMed ID: 6414749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigens shared by leukemic blast cell and lymphoblastoid cell lines detected by lymphocyte-dependent antibody.
    Durantez A; Zighelboim J; Thieme T; Fahey JL
    Cancer Res; 1975 Oct; 35(10):2693-8. PubMed ID: 1057451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of both T-cell and Ia-like antigens on cells from patients with acute myelomonocytic leukemia and chronic myelogenous leukemia in blast crisis.
    Anderson JK; Moore JO; Metzgar RS
    Cancer Res; 1979 Dec; 39(12):4810-5. PubMed ID: 91428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stimulated lymphoid cells of B lineage, but not plasma or myeloid cells, can express E receptor.
    Mills KH; Cawley JC
    Leuk Res; 1985; 9(3):375-80. PubMed ID: 3158785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular sensitization in chronic myeloid leukaemia patients to leukaemic blast antigens.
    Gangal SG; Damle NK; Khare AG; Advani SH
    Br J Cancer; 1979 Sep; 40(3):391-6. PubMed ID: 292450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute lymphoblastic leukemia (ALL) antigens detected with antisera to E rosette-froming and non-E rosette-forming ALL blasts.
    Borella L; Sen L; Casper JT
    J Immunol; 1977 Jan; 118(1):309-15. PubMed ID: 318669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytotoxicity of antisera to a myelogenous leukemia cell line with the Philadelphia chromosome.
    Whitson ME; Lozzio CB; Lozzio BB; Wust CJ; Sonoda T; Avery B
    J Natl Cancer Inst; 1976 May; 56(5):903-7. PubMed ID: 1069137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Receptors for complement and immunoglobulin on human leukemic cells and human lymphoblastoid cell lines.
    Shevach EM; Herberman R; Frank MM; Green I
    J Clin Invest; 1972 Aug; 51(8):1933-8. PubMed ID: 4506240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specificity of heteroantisera to human acute leukemia-associated antigens.
    Baker MA; Ramachandar K; Taub RN
    J Clin Invest; 1974 Dec; 54(6):1273-8. PubMed ID: 4140196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reaction of various human normal and leukemic cells and cells of different cell lines with rabbit antisera prepared against membrane fraction of B and T cell lines.
    Koubek K
    Neoplasma; 1983; 30(2):187-95. PubMed ID: 6188960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell surface antigens detected on mature and leukemic granulocytic populations by cytotoxicity testing.
    Drew SI; Carter BM; Terasaki PI; Naiem F; Nathanson DS; Abromowitz B; Gale RP
    Tissue Antigens; 1978 Aug; 12(2):75-86. PubMed ID: 100897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serological analysis of cell surface antigens of HL-60 cells before and after treatment with a phorbol ester tumor promoter.
    Namikawa R; Ogata S; Ueda R; Tsuge I; Nishida K; Minami S; Koike K; Suchi T; Ota K; Iijima S; Takahashi T
    Leuk Res; 1983; 7(3):375-87. PubMed ID: 6604202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.